Aytu BioPharma, Inc. Common Stock (NASDAQ: AYTU) last traded at $2.37, up 3.95% on the session. The quote above updates while this page is open; the figures below are drawn from Aytu BioPharma, Inc. Common Stock’s own filings and are restated only when a new one is published.
Aytu BioPharma, Inc. Common Stock trades on NASDAQ under the ticker AYTU. Its market capitalisation is $25.44 million.
Valuation measures for Aytu BioPharma, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $25.44M |
|---|---|
| Price / sales | 0.45 |
| Price / book | 0.72 |
| Beta | 0.80 |
Trailing-twelve-month figures tagged in Aytu BioPharma, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $56.60M |
|---|---|
| Net income (TTM) | -$34.05M |
| EPS (TTM) | -$3.62 |
| Gross margin | 64.78% |
| Operating margin | -26.79% |
| Return on equity | -96.90% |
| Cash | $26.71M |
Range and volume for AYTU over the past 52 weeks.
| 52-week high | $3.07 |
|---|---|
| 52-week low | $1.65 |
| Volume | 52.3K |
| Average volume | 29.0K |
| Previous close | $2.28 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.